FI66623C - Molekylkoordinationskomplex och foerfarande foer dess framstaellning - Google Patents

Molekylkoordinationskomplex och foerfarande foer dess framstaellning Download PDF

Info

Publication number
FI66623C
FI66623C FI803848A FI803848A FI66623C FI 66623 C FI66623 C FI 66623C FI 803848 A FI803848 A FI 803848A FI 803848 A FI803848 A FI 803848A FI 66623 C FI66623 C FI 66623C
Authority
FI
Finland
Prior art keywords
polymer
alcohol
weight
cellulose
cellulosic polymer
Prior art date
Application number
FI803848A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI803848L (fi
FI66623B (fi
Inventor
Stewart Thomas Leslie
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of FI803848L publication Critical patent/FI803848L/fi
Application granted granted Critical
Publication of FI66623B publication Critical patent/FI66623B/fi
Publication of FI66623C publication Critical patent/FI66623C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
FI803848A 1979-12-19 1980-12-10 Molekylkoordinationskomplex och foerfarande foer dess framstaellning FI66623C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IE248179 1979-12-19
IE248079 1979-12-19
IE2480/79A IE49324B1 (en) 1979-12-19 1979-12-19 Controlled release compositions
IE248179 1979-12-19

Publications (3)

Publication Number Publication Date
FI803848L FI803848L (fi) 1981-06-20
FI66623B FI66623B (fi) 1984-07-31
FI66623C true FI66623C (fi) 1984-11-12

Family

ID=26319271

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803848A FI66623C (fi) 1979-12-19 1980-12-10 Molekylkoordinationskomplex och foerfarande foer dess framstaellning

Country Status (27)

Country Link
US (1) US4366310A (cs)
EP (1) EP0032004B1 (cs)
JP (1) JPS5698201A (cs)
AU (1) AU541246B2 (cs)
BE (1) BE886711A (cs)
CA (1) CA1168230A (cs)
CS (1) CS228142B2 (cs)
DE (1) DE3048028A1 (cs)
DK (1) DK170347B1 (cs)
EG (1) EG14984A (cs)
ES (1) ES497906A0 (cs)
FI (1) FI66623C (cs)
FR (1) FR2474507B1 (cs)
GB (1) GB2067569B (cs)
GR (1) GR72265B (cs)
HU (1) HU188085B (cs)
IE (1) IE49324B1 (cs)
IL (1) IL61677A (cs)
MX (1) MX158088A (cs)
NL (1) NL187401C (cs)
NO (1) NO152846C (cs)
NZ (1) NZ195793A (cs)
PL (1) PL133079B1 (cs)
PT (1) PT72214B (cs)
SU (1) SU1178326A3 (cs)
YU (1) YU40957B (cs)
ZA (1) ZA807716B (cs)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
DE3306621A1 (de) * 1983-02-25 1984-08-30 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von celluloseethern mit einem dimethoxyethan enthaltenden dispergierhilfsmittel
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5476668A (en) * 1990-08-24 1995-12-19 Shin-Etsu Chemical Co., Ltd. Base for film-coating pharmaceuticals and method for preparing same
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU8532798A (en) * 1997-06-13 1998-12-30 Roland Bodmeier Compounds which delay the release of active substances
DK1685839T3 (da) 1997-12-22 2013-06-24 Euro Celtique Sa Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
AU776666B2 (en) 2000-02-08 2004-09-16 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
US7943173B2 (en) 2001-07-18 2011-05-17 Purdue Pharma L.P. Pharmaceutical combinations of oxycodone and naloxone
WO2003013525A1 (en) 2001-08-06 2003-02-20 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
CA2478515C (en) 2002-04-05 2010-09-28 Purdue Pharma Pharmaceutical preparation containing oxycodone and naloxone
DK1551372T3 (en) 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1765292B1 (en) 2004-06-12 2017-10-04 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
KR101486228B1 (ko) 2006-06-19 2015-01-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
WO2010103039A1 (en) 2009-03-10 2010-09-16 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2011141490A1 (en) 2010-05-10 2011-11-17 Euro-Celtique S.A. Combination of active loaded granules with additional actives
NZ603173A (en) 2010-05-10 2014-10-31 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
KR20130030260A (ko) 2010-05-10 2013-03-26 유로-셀티큐 에스.에이. 히드로모르폰 및 날록손을 포함하는 제약 조성물
EP2826467B1 (en) 2010-12-22 2017-08-02 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
CN105120846B (zh) 2013-02-05 2019-10-18 普渡制药公司 抗篡改的药物制剂
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
KR20180037074A (ko) 2013-07-23 2018-04-10 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
EP3068397A1 (en) 2013-11-13 2016-09-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3988482A (en) * 1971-08-27 1976-10-26 Toyo Hakka Kogyo Kabushiki Kaisha Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
US3899439A (en) * 1973-03-12 1975-08-12 Hercules Inc Method of preparing aqueous dispersions of hydroxypropyl cellulose
DE2644678A1 (de) * 1976-10-02 1978-04-06 Dynamit Nobel Ag Verfahren zur herstellung funktionalisierter cellulosen
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4259355A (en) * 1979-03-05 1981-03-31 International Flavors & Fragrances Inc. Chewing gum containing flavor composition and flavor composition therefor
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
PT72214A (en) 1980-08-01
FI803848L (fi) 1981-06-20
FR2474507A1 (fr) 1981-07-31
HUT34891A (en) 1985-05-28
SU1178326A3 (ru) 1985-09-07
AU6529880A (en) 1981-06-25
US4366310A (en) 1982-12-28
PL133079B1 (en) 1985-05-31
NL187401C (nl) 1991-09-16
BE886711A (fr) 1981-06-17
NO803836L (no) 1981-06-22
EG14984A (en) 1986-06-30
IL61677A (en) 1984-10-31
DK170347B1 (da) 1995-08-07
GB2067569A (en) 1981-07-30
EP0032004A2 (en) 1981-07-15
AU541246B2 (en) 1985-01-03
JPH0225921B2 (cs) 1990-06-06
CS228142B2 (en) 1984-05-14
ZA807716B (en) 1981-12-30
PT72214B (en) 1981-11-02
IE49324B1 (en) 1985-09-18
EP0032004B1 (en) 1985-05-15
MX158088A (es) 1989-01-06
NZ195793A (en) 1982-09-14
EP0032004A3 (en) 1982-07-14
GB2067569B (en) 1983-09-01
JPS5698201A (en) 1981-08-07
NL187401B (nl) 1991-04-16
CA1168230A (en) 1984-05-29
NO152846C (no) 1985-11-27
ES8303489A1 (es) 1983-02-01
IE792480L (en) 1981-06-19
HU188085B (en) 1986-03-28
NL8006891A (nl) 1981-07-16
FI66623B (fi) 1984-07-31
ES497906A0 (es) 1983-02-01
IL61677A0 (en) 1981-01-30
PL228573A1 (cs) 1982-07-19
DE3048028A1 (de) 1981-09-10
YU40957B (en) 1986-08-31
FR2474507B1 (fr) 1986-12-26
GR72265B (cs) 1983-10-10
YU321080A (en) 1983-06-30
DK527680A (da) 1981-08-05
NO152846B (no) 1985-08-19

Similar Documents

Publication Publication Date Title
FI66623B (fi) Molekylkoordinationskomplex och foerfarande foer dess framstaellning
Lenaerts et al. Controlled release of theophylline from cross-linked amylose tablets
US4842866A (en) Slow release solid preparation
US3773920A (en) Sustained release medicinal composition
FI100219B (fi) Menetelmä farmaseuttisen granulaatin valmistamiseksi
US5456921A (en) Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
DE1258548C2 (de) Verfahren zur Herstellung von Arzneimitteltabletten unter Verwendung von Kunstharzen als die Wirkstoffabgabe verzoegernde Einbettungsmassen
EP0559813B1 (en) Controlled release compositions
EP0250374B1 (en) Therapeutic system for controlled release of drugs
EP1429735A2 (de) Verfahren und vorrichtung zur herstellung von granulaten umfassend mindestens einen pharmazeutischen wirkstoff
CA1079638A (en) Coated granules of polyacrylic alkali metal salts and method of producing same
US4267138A (en) Coating ensuring a controlled release of active ingredients of biologically active compositions, particularly pharmaceutical compositions and a process for preparation of biologically active compositions ensuring controlled release of active ingredients
US3836618A (en) Process for the uniform distribution of a drug on a granulated base
KR0177493B1 (ko) 단사정계 결정구조를 갖고 감열, 감광 및 감습성이 있는 활성성분을 함유하는 정제의 제조방법
DE69325236T2 (de) Pharmazeutische Zusammensetzungen enthaltend Urodeoxycholicsäure
DD209575A5 (de) Verfahren zur herstellung eines pharmazeutischen produktes in anhaltend freisetzender form
DE4127522A1 (de) Neue masse mit einem hydrophilen polymer und einem davon verschiedenen hydrophilen material
US4218333A (en) Process for the preparation of pharmaceutical substance-containing microcapsules
DE112006001853T5 (de) Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten
GB2192128A (en) Production of pharmaceutical unit dosage forms
Makino et al. Importance of gelatinization degree of starch paste binder in hardness and disintegration time of tablets
DE60311796T2 (de) Methode zur verbesserung der oberflächeneigenschaften von tabletten
AoKI et al. Sustained-release matrix using hydroxypropylcellulose-ethylcellulose complex as a filler, and controlling factors of drug release
WAN et al. Action of methylcellulose on disintegration and dissolution properties of tablets
JPS60141694A (ja) 崩壊性粒状苦土肥料及び崩壊性粒状石灰質肥料の製造方法

Legal Events

Date Code Title Description
MA Patent expired

Owner name: EURO-CELTIQUE, S.A.